DCF — CITIZENS MEDICAL CENTER
Enterprise Value: $-105.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-105.4M
Enterprise Value
$-32.8M
PV of Cash Flows
$-72.5M
PV of Terminal Value
$-116.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $50.9M | $-6.8M | -13.0% | $-9.0M | $-8.2M |
| Year 2 | $52.5M | $-6.5M | -12.0% | $-8.7M | $-7.2M |
| Year 3 | $54.0M | $-6.2M | -11.0% | $-8.5M | $-6.4M |
| Year 4 | $55.7M | $-6.1M | -11.0% | $-8.4M | $-5.8M |
| Year 5 | $57.3M | $-6.1M | -11.0% | $-8.5M | $-5.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-105.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$49.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.139260365117782
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5